Phase 2 Ovarian Cancer Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The person must provide written agreement to take part before any trial-related procedures begin.
- The person must be older than 10 years of age.
- The person must have a good general health and activity level, rated 0 or 1 on a standard medical scale (meaning fully active or able to carry out light work).
- The person must be expected to live for at least 12 weeks.
- The person must have a confirmed diagnosis of high-risk gynecological cancer (specifically FIGO Stage II–IV), proven through tissue testing.
- The person must not be pregnant, and must be using appropriate contraception if there is any possibility of becoming pregnant.
- The person must have adequate blood cell counts, specifically: white blood cells (neutrophils) at or above 1,000/mm³, and platelets at or above 100,000/mm³.
- The person must have kidney and liver function within acceptable ranges, including: creatinine no more than twice the upper normal limit; bilirubin no more than twice the upper normal limit (a slightly higher bilirubin level may be accepted if a condition called Gilbert's syndrome has been diagnosed); liver enzymes (AST and ALT) no more than twice the upper normal limit; and another liver marker (alkaline phosphatase) no more than five times the upper normal limit.
- The person must have tested negative for HIV and Hepatitis C virus.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a type of ovarian tumour considered "borderline" (low malignant potential) rather than fully cancerous.
- People who have unexplained free air in the abdomen (not caused by a recent medical procedure or surgery).
- People who have previously received any treatment involving adoptive T cell therapy (a type of immune cell treatment).
- People who have received immune-suppressing medications within the 14 days before the trial start date.
- People who have had a minor surgical procedure within 2 days before the trial start date, including procedures such as placing a central venous line, tumour biopsy, or needle aspiration.
- People who are pregnant or currently breastfeeding.
- People whose bone marrow is not producing enough blood cells, specifically: neutrophils below 1,000/mm³; platelets below 100,000/mm³; or haemoglobin below 9 g/dL.
- People whose liver or kidney function falls outside acceptable limits, including: total bilirubin above 1.5 times the upper normal limit; AST and ALT above 2.5 times the upper normal limit (or above 5 times the upper normal limit if cancer has spread to the liver); alkaline phosphatase above 2.5 times the upper normal limit; creatinine above 2.0 mg/dL; or protein in the urine above certain measured levels (confirm with trial site for full urine testing details).
- People who have a serious active infection currently being treated with intravenous (IV) antibiotics.
- People who have tested positive for Hepatitis C, HIV, syphilis (Treponema pallidum), or tuberculosis (TB).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of OC-EIEs in patients using CTCAE version 4.0 standard to evaluate the level of adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.